Phase 2b Study in NASH to Assess IVA337

NCT03008070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: IVA337
DRUG: IVA337
DRUG: Placebo

Sponsor

Inventiva Pharma